Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Sikorski TW"'
Autor:
Chen Z; Precision Medicine, GSK, Collegeville, Pennsylvania, USA., Goudarzi CC; Precision Medicine, GSK, Collegeville, Pennsylvania, USA., Sikorski TW; Precision Medicine, GSK, Collegeville, Pennsylvania, USA., Weng N; Precision Medicine, GSK, Collegeville, Pennsylvania, USA.
Publikováno v:
Journal of mass spectrometry : JMS [J Mass Spectrom] 2024 May; Vol. 59 (5), pp. e5023.
Autor:
Schneck NA; Bioanalysis, Immunogenicity & Biomarkers, GSK, 1250 S. Collegeville Rd, Collegeville, PA 19426, USA., Mortezavi L; Bioanalysis, Immunogenicity & Biomarkers, GSK, 1250 S. Collegeville Rd, Collegeville, PA 19426, USA., Olzinski AR; Novel Human Genetics Research Unit, GSK, 1250 S. Collegeville Rd, Collegeville, PA 19426, USA., Posavec D; Novel Human Genetics Research Unit, GSK, 1250 S. Collegeville Rd, Collegeville, PA 19426, USA., Jolivette LJ; Drug Metabolism & Pharmacokinetics, GSK, 1250 S. Collegeville Rd, Collegeville, PA 19426, USA., Sikorski TW; Bioanalysis, Immunogenicity & Biomarkers, GSK, 1250 S. Collegeville Rd, Collegeville, PA 19426, USA., Zhang SS; Therapeutics Division, 23andMe, 349 Oyster Point Blvd, South San Francisco, CA 94080, USA., Schnackenberg CG; Novel Human Genetics Research Unit, GSK, 1250 S. Collegeville Rd, Collegeville, PA 19426, USA., Licea-Perez H; Bioanalysis, Immunogenicity & Biomarkers, GSK, 1250 S. Collegeville Rd, Collegeville, PA 19426, USA.
Publikováno v:
Bioanalysis [Bioanalysis] 2023 Oct; Vol. 15 (19), pp. 1169-1178. Date of Electronic Publication: 2023 Sep 07.
Autor:
Pu J; Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York 14214, United States., Xue C; Department of Chemical and Biological Engineering, University at Buffalo, State University of New York, Buffalo, New York 14214, United States., Huo S; Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York 14214, United States., Shen Q; Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York 14214, United States., Qu Y; Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York 14214, United States.; New York State Center of Excellence in Bioinformatics and Life Sciences, Buffalo, New York 14203, United States., Yang X; Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York 14214, United States., An B; Bioanalysis, Immunogenicity & Biomarkers, In-Vitro/In-Vivo Translation, R&D Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., Angel TE; Bioanalysis, Immunogenicity & Biomarkers, In-Vitro/In-Vivo Translation, R&D Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., Chen Z; Bioanalysis, Immunogenicity & Biomarkers, In-Vitro/In-Vivo Translation, R&D Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., Mehl JT; Bioanalysis, Immunogenicity & Biomarkers, In-Vitro/In-Vivo Translation, R&D Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., Tang H; Bioanalysis, Immunogenicity & Biomarkers, In-Vitro/In-Vivo Translation, R&D Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., Yang E; Bioanalysis, Immunogenicity & Biomarkers, In-Vitro/In-Vivo Translation, R&D Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., Sikorski TW; Bioanalysis, Immunogenicity & Biomarkers, In-Vitro/In-Vivo Translation, R&D Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., Qu J; Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York 14214, United States.; New York State Center of Excellence in Bioinformatics and Life Sciences, Buffalo, New York 14203, United States.
Publikováno v:
Analytical chemistry [Anal Chem] 2023 Jan 17; Vol. 95 (2), pp. 924-934. Date of Electronic Publication: 2022 Dec 19.
Autor:
An B; Bioanalysis, Immunogenicity & Biomarkers, In-vitro/In-vivo Translation, R&D Research, GlaxoSmithKline, 1250 South Collegeville Rd, Collegeville, PA 19426, USA. Electronic address: bo.x.an@gsk.com., Sikorski TW; Bioanalysis, Immunogenicity & Biomarkers, In-vitro/In-vivo Translation, R&D Research, GlaxoSmithKline, 1250 South Collegeville Rd, Collegeville, PA 19426, USA., Kellie JF; Bioanalysis, Immunogenicity & Biomarkers, In-vitro/In-vivo Translation, R&D Research, GlaxoSmithKline, 1250 South Collegeville Rd, Collegeville, PA 19426, USA., Chen Z; Bioanalysis, Immunogenicity & Biomarkers, In-vitro/In-vivo Translation, R&D Research, GlaxoSmithKline, 1250 South Collegeville Rd, Collegeville, PA 19426, USA., Schneck NA; Bioanalysis, Immunogenicity & Biomarkers, In-vitro/In-vivo Translation, R&D Research, GlaxoSmithKline, 1250 South Collegeville Rd, Collegeville, PA 19426, USA., Mehl J; Bioanalysis, Immunogenicity & Biomarkers, In-vitro/In-vivo Translation, R&D Research, GlaxoSmithKline, 1250 South Collegeville Rd, Collegeville, PA 19426, USA., Tang H; Bioanalysis, Immunogenicity & Biomarkers, In-vitro/In-vivo Translation, R&D Research, GlaxoSmithKline, 1250 South Collegeville Rd, Collegeville, PA 19426, USA., Qu J; Department of Pharmaceutical Sciences, School of Pharmacy & Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, NY 14214, USA; New York State Center of Excellence in Bioinformatics & Life Sciences, Buffalo, NY 14203, USA., Shi T; Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352, USA., Gao Y; Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352, USA., Jacobs JM; Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352, USA., Nandita E; SCIEX, 1201 Radio Road, Redwood City, CA 94065, USA., van Soest R; SCIEX, 1201 Radio Road, Redwood City, CA 94065, USA., Jones E; SCIEX, 1201 Radio Road, Redwood City, CA 94065, USA.
Publikováno v:
Journal of chromatography. A [J Chromatogr A] 2022 Aug 02; Vol. 1676, pp. 463261. Date of Electronic Publication: 2022 Jun 17.
Autor:
Khanal N; Bioanalysis, Immunogenicity & Biomarkers, In-vitro/In-vivo Translation, Research, GlaxoSmithKline, 1250 South Collegeville Rd., Collegeville, PA 19426, USA.; Scientific Operations, Waters Corporation, 34 Maple Street, Milford, MA 01757, USA., Chen Z; Bioanalysis, Immunogenicity & Biomarkers, In-vitro/In-vivo Translation, Research, GlaxoSmithKline, 1250 South Collegeville Rd., Collegeville, PA 19426, USA., Alelyunas YW; Scientific Operations, Waters Corporation, 34 Maple Street, Milford, MA 01757, USA., Szapacs ME; Bioanalysis, Immunogenicity & Biomarkers, In-vitro/In-vivo Translation, Research, GlaxoSmithKline, 1250 South Collegeville Rd., Collegeville, PA 19426, USA., Wrona MD; Scientific Operations, Waters Corporation, 34 Maple Street, Milford, MA 01757, USA., Sikorski TW; Bioanalysis, Immunogenicity & Biomarkers, In-vitro/In-vivo Translation, Research, GlaxoSmithKline, 1250 South Collegeville Rd., Collegeville, PA 19426, USA.
Publikováno v:
Bioanalysis [Bioanalysis] 2022 Mar 08. Date of Electronic Publication: 2022 Mar 08.
Autor:
Noto PB; Experimental Medicine Unit, Oncology R&D, GSK, Collegeville, USA. paul.x.noto@gsk.com., Sikorski TW; Protein Mass Spectrometry, In Vitro/In Vivo Translation, Research, GSK, Collegeville, USA., Zappacosta F; Discovery Analytical, Medicinal Science and Technology, Research, GSK, Collegeville, USA., Wagner CD; Discovery Analytical, Medicinal Science and Technology, Research, GSK, Collegeville, USA., Montes de Oca R; Experimental Medicine Unit, Oncology R&D, GSK, Collegeville, USA., Szapacs ME; Protein Mass Spectrometry, In Vitro/In Vivo Translation, Research, GSK, Collegeville, USA., Annan RS; Discovery Analytical, Medicinal Science and Technology, Research, GSK, Collegeville, USA., Liu Y; Epigenetics, Oncology R&D, GSK, Collegeville, USA., McHugh CF; Discovery DMPK, In Vitro / In Vivo Translation, Research, GSK, Collegeville, USA., Mohammad HP; Epigenetics, Oncology R&D, GSK, Collegeville, USA., Piccoli SP; Experimental Medicine Unit, Oncology R&D, GSK, Collegeville, USA.; Clinical Biomarkers and Diagnostics, Sun Pharmaceutical Advanced Research Center (SPARC), Princeton, USA., Creasy CL; Epigenetics, Oncology R&D, GSK, Collegeville, USA.
Publikováno v:
Scientific reports [Sci Rep] 2020 Dec 17; Vol. 10 (1), pp. 22155. Date of Electronic Publication: 2020 Dec 17.
Autor:
Chen Z; Bioanalysis, Immunogenicity & Biomarkers, In-vitro/In-vivo Translation, R&D Research, GlaxoSmithKline Pharmaceuticals, 1250 South Collegeville Rd, Collegeville, PA 19426, USA., Sikorski TW; Bioanalysis, Immunogenicity & Biomarkers, In-vitro/In-vivo Translation, R&D Research, GlaxoSmithKline Pharmaceuticals, 1250 South Collegeville Rd, Collegeville, PA 19426, USA.
Publikováno v:
Bioanalysis [Bioanalysis] 2020 Sep; Vol. 12 (17), pp. 1219-1222. Date of Electronic Publication: 2020 Aug 21.
Autor:
Kellie JF; Bioanalysis, Immunogenicity & Biomarkers, 1250 S Collegeville Rd, Collegeville, PA 19426, USA., Sikorski TW; Bioanalysis, Immunogenicity & Biomarkers, 1250 S Collegeville Rd, Collegeville, PA 19426, USA., An B; Bioanalysis, Immunogenicity & Biomarkers, 1250 S Collegeville Rd, Collegeville, PA 19426, USA., Chen Z; Bioanalysis, Immunogenicity & Biomarkers, 1250 S Collegeville Rd, Collegeville, PA 19426, USA., Moghieb AH; Bioanalysis, Immunogenicity & Biomarkers, 1250 S Collegeville Rd, Collegeville, PA 19426, USA., Busz MG; Bioanalysis, Immunogenicity & Biomarkers, 1250 S Collegeville Rd, Collegeville, PA 19426, USA., Szapacs ME; Bioanalysis, Immunogenicity & Biomarkers, 1250 S Collegeville Rd, Collegeville, PA 19426, USA., Angel TE; Bioanalysis, Immunogenicity & Biomarkers, 1250 S Collegeville Rd, Collegeville, PA 19426, USA.
Publikováno v:
Bioanalysis [Bioanalysis] 2019 Oct; Vol. 11 (19), pp. 1731-1735. Date of Electronic Publication: 2019 Oct 16.
Autor:
Sikorski TW; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115; Department of Cancer Biology, Harvard Medical School, Boston, Massachusetts 02115., Joo YJ; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115., Ficarro SB; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115; Department of Cancer Biology, Harvard Medical School, Boston, Massachusetts 02115; Blais Proteomics Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115., Askenazi M; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115; Department of Cancer Biology, Harvard Medical School, Boston, Massachusetts 02115; Blais Proteomics Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115., Buratowski S; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115. Electronic address: steveb@hms.harvard.edu., Marto JA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115; Department of Cancer Biology, Harvard Medical School, Boston, Massachusetts 02115; Blais Proteomics Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115. Electronic address: jarrod_marto@dfci.harvard.edu.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2012 Oct 12; Vol. 287 (42), pp. 35397-35408. Date of Electronic Publication: 2012 Aug 17.
Autor:
Sikorski TW; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA., Ficarro SB, Holik J, Kim T, Rando OJ, Marto JA, Buratowski S
Publikováno v:
Molecular cell [Mol Cell] 2011 Nov 04; Vol. 44 (3), pp. 397-409.